X-52813228-G-A

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001386970.1(XAGE5):​c.161G>A​(p.Gly54Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000745 in 1,208,231 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000090 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.0000073 ( 0 hom. 4 hem. )

Consequence

XAGE5
NM_001386970.1 missense

Scores

1
2
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.205
Variant links:
Genes affected
XAGE5 (HGNC:30930): (X antigen family member 5) This gene is a member of the XAGE subfamily, which belongs to the GAGE family. The GAGE genes are expressed in a variety of tumors and in some fetal and reproductive tissues. The protein encoded by this gene shares a sequence similarity with other GAGE/PAGE proteins. Because of the expression pattern and the sequence similarity, this protein also belongs to a family of CT (cancer-testis) antigens. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.058345407).
BS2
High Hemizygotes in GnomAdExome4 at 4 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
XAGE5NM_001386970.1 linkuse as main transcriptc.161G>A p.Gly54Asp missense_variant 4/6 ENST00000375501.2 NP_001373899.1
XAGE5NM_130775.3 linkuse as main transcriptc.161G>A p.Gly54Asp missense_variant 3/5 NP_570131.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
XAGE5ENST00000375501.2 linkuse as main transcriptc.161G>A p.Gly54Asp missense_variant 4/65 NM_001386970.1 ENSP00000364651 P1
XAGE5ENST00000375503.7 linkuse as main transcriptc.161G>A p.Gly54Asp missense_variant, NMD_transcript_variant 2/51 ENSP00000364653

Frequencies

GnomAD3 genomes
AF:
0.00000898
AC:
1
AN:
111297
Hom.:
0
Cov.:
22
AF XY:
0.00
AC XY:
0
AN XY:
33487
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000284
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000383
AC:
7
AN:
182567
Hom.:
0
AF XY:
0.0000298
AC XY:
2
AN XY:
67163
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000506
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000729
AC:
8
AN:
1096880
Hom.:
0
Cov.:
30
AF XY:
0.0000110
AC XY:
4
AN XY:
362364
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000265
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000898
AC:
1
AN:
111351
Hom.:
0
Cov.:
22
AF XY:
0.00
AC XY:
0
AN XY:
33551
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000285
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000756
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 03, 2024The c.161G>A (p.G54D) alteration is located in exon 3 (coding exon 2) of the XAGE5 gene. This alteration results from a G to A substitution at nucleotide position 161, causing the glycine (G) at amino acid position 54 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
9.3
DANN
Uncertain
0.99
DEOGEN2
Benign
0.080
T;T
FATHMM_MKL
Benign
0.0048
N
LIST_S2
Benign
0.63
T;.
M_CAP
Benign
0.0014
T
MetaRNN
Benign
0.058
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Pathogenic
3.0
M;M
MutationTaster
Benign
1.0
N;N;N;N
PrimateAI
Benign
0.44
T
PROVEAN
Uncertain
-3.8
D;D
REVEL
Benign
0.093
Sift
Benign
0.066
T;T
Sift4G
Benign
0.098
T;T
Polyphen
0.56
P;P
Vest4
0.17
MutPred
0.58
Gain of solvent accessibility (P = 0.0638);Gain of solvent accessibility (P = 0.0638);
MVP
0.13
MPC
0.0036
ClinPred
0.24
T
GERP RS
0.65
Varity_R
0.47
gMVP
0.011

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs782630066; hg19: chrX-52842252; API